Anti-CA9重组抗体|科研级 Girentuximab ( 吉妥昔单抗 )-Product Center-Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

Anti-CA9重组抗体|科研级 Girentuximab ( 吉妥昔单抗 )

Detailed related information Target background information Experimental Plan&FAQ Related products Recommended Services

询价与订购

Name*
Phone*
Email*
Product*
Content*

Anti-CA9重组抗体|科研级 Girentuximab ( 吉妥昔单抗 )

instructions Contact

< >

CatNo：TKYR1222

Price

WeChat QR
Contact Us

instructions
MSDSWeChat QR
Contact Us

Detailed

Background

Plan&FAQ

Recommended

Detailed related information

Catalog Number

TKYR1222

Alias

科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab

Molecular Name

Girentuximab

Size

1mg, 5mg

CAS Number

916138-87-9

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Applications

WB, FuncS, IF, Neut, ELISA, FC, IP, PK, IHC, Activ

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

CA9[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Girentuximab (trade name Rencarex) is a chimeric IgG1 monoclonal antibody to carbonic anhydrase IX (CAIX). CAIX is expressed on the surface of most renal cancer cells and is hypothesized to be on the surface of other tumor cells. It is investigational agent in clinical trials for renal cell carcinoma. Its development was suspended as a "naked" or unconjugated antibody during phase III trials due to efficacy.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

Target background information

Experimental Plan&FAQ